ID   L1210
AC   CVCL_0382
SY   L 1210; L-1210; Leukemic 1210; Leukemia 1210; Leukemia L1210
DR   BTO; BTO:0000702
DR   CLO; CLO_0007139
DR   CLO; CLO_0007155
DR   CLO; CLO_0007156
DR   EFO; EFO_0005284
DR   MCCL; MCC:0000277
DR   CLDB; cl3111
DR   CLDB; cl3112
DR   CLDB; cl3113
DR   CLDB; cl3114
DR   CLDB; cl3115
DR   CLDB; cl4936
DR   CLDB; cl5219
DR   ATCC; CCL-219
DR   BCRC; 60049
DR   BCRJ; 0138
DR   BioSample; SAMN11397625
DR   CCRID; 1101MOU-PUMC000191
DR   CCRID; 4201MOU-CCTCC00203
DR   CCRID; 6101MOU-CERC000108
DR   ChEMBL-Cells; CHEMBL3308391
DR   ChEMBL-Targets; CHEMBL386
DR   CLS; 400257
DR   DSMZ; ACC-123
DR   DSMZCellDive; ACC-123
DR   ECACC; 87092804
DR   GEO; GSM1112425
DR   GEO; GSM1112426
DR   ICLC; ATL99002
DR   KCB; KCB 200774YJ
DR   KCLB; 10219
DR   MeSH; D007939
DR   TKG; TKG 0154
DR   Wikidata; Q6456824
RX   PubMed=6970130;
RX   PubMed=18630317;
RX   PubMed=25277546;
RX   PubMed=31220119;
CC   Part of: ENCODE project mouse cell lines.
CC   Doubling time: 10-12 hours (CLS); ~50 hours (DSMZ).
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Omics: SNP array analysis.
CC   Derived from sampling site: Ascites.
CC   Breed/subspecies: DBA/2.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15,17
ST   Mouse STR 1-2: 16
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 12
ST   Mouse STR 2-1: 15
ST   Mouse STR 3-2: 13
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 13
ST   Mouse STR 6-4: 17
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 27,28
ST   Mouse STR 8-1: 16
ST   Mouse STR X-1: 27
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 23-06-22; Version: 26
RX   PubMed=6970130; DOI=10.1002/eji.1830101111;
RA   Conzelmann A., Pink R., Acuto O., Mach J.-P., Dolivo S., Nabholz M.;
RT   "Presence of T 145 on cytolytic T cell lines and their
RT   lectin-resistant mutants.";
RL   Eur. J. Immunol. 10:860-868(1980).
RX   PubMed=18630317; DOI=10.1093/jnci/36.3.405;
RA   Moore G.E., Sandberg A.A., Ulrich K.;
RT   "Suspension cell culture and in vivo and in vitro chromosome
RT   constitution of mouse leukemia L1210.";
RL   J. Natl. Cancer Inst. 36:405-413(1966).
RX   PubMed=25277546; DOI=10.1186/1471-2164-15-847;
RA   Didion J.P., Buus R.J., Naghashfar Z., Threadgill D.W.,
RA   Morse H.C. III, Pardo-Manuel de Villena F.;
RT   "SNP array profiling of mouse cell lines identifies their strains of
RT   origin and reveals cross-contamination and widespread aneuploidy.";
RL   BMC Genomics 15:847.1-847.11(2014).
RX   PubMed=31220119; DOI=10.1371/journal.pone.0218412;
RA   Almeida J.L., Dakic A., Kindig K., Kone M., Letham D.L.D., Langdon S.,
RA   Peat R., Holding-Pillai J., Hall E.M., Ladd M., Shaffer M.D., Berg H.,
RA   Li J.-L., Wigger G., Lund S., Steffen C.R., Fransway B.B., Geraghty B.,
RA   Natoli M., Bauer B., Gollin S.M., Lewis D.W., Reid Y.A.;
RT   "Interlaboratory study to validate a STR profiling method for
RT   intraspecies identification of mouse cell lines.";
RL   PLoS ONE 14:E0218412-E0218412(2019).